Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 K-ras mutations in the plasma correspond to computed tomographic findings in patients with pancreatic cancer.

× No keyword cloud information.

9 in total

1. Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer.

Authors: Kjersti Tjensvoll; Morten Lapin; Tove Buhl; Satu Oltedal; Katrine Steen-Ottosen Berry; Bjørnar Gilje; Jon Arne Søreide; Millind Javle; Oddmund Nordgård; Rune Smaaland
Journal: Mol Oncol Date: 2015-12-15 Impact factor: 6.603

2. CA 19-9 and pancreatic cancer.

Authors: Erxi Wu; Shuang Zhou; Kruttika Bhat; Qingyong Ma
Journal: Clin Adv Hematol Oncol Date: 2013-01

Review 3. Circulating biomarkers to monitor cancer progression and treatment.

Authors: Suthee Rapisuwon; Eveline E Vietsch; Anton Wellstein
Journal: Comput Struct Biotechnol J Date: 2016-06-01 Impact factor: 7.271

4. Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer.

Authors: Marzia Del Re; Caterina Vivaldi; Eleonora Rofi; Enrico Vasile; Mario Miccoli; Chiara Caparello; Paolo Davide d'Arienzo; Lorenzo Fornaro; Alfredo Falcone; Romano Danesi
Journal: Sci Rep Date: 2017-08-11 Impact factor: 4.379

5. Correlation Between Circulating Tumor DNA Levels and Response to Tyrosine Kinase Inhibitors (TKI) Treatment in Non-Small Cell Lung Cancer.

Authors: Zhangjing Wei; Wenyue Wang; Zitan Shu; Xue Zhou; Yanfang Zhang
Journal: Med Sci Monit Date: 2017-07-25

Review 6. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.

Authors: Erina Takai; Shinichi Yachida
Journal: World J Gastroenterol Date: 2016-10-14 Impact factor: 5.742

Review 7. Tumour biomarkers-Tracing the molecular function and clinical implication.

Authors: Jiahao Lin; Lie Ma; Di Zhang; Jiafeng Gao; Yipeng Jin; Zhihai Han; Degui Lin
Journal: Cell Prolif Date: 2019-03-14 Impact factor: 6.831

8. Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?

Authors: Tamara M H Gall; Gareth Gerrard; Adam E Frampton; Leandro Castellano; Raida Ahmad; Nagy Habib; Duncan Spalding; Madhava Pai; Letizia Foroni; Long R Jiao
Journal: Oncotarget Date: 2019-01-22

9. Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Pancreatic Cancer.

Authors: Ronghua Wang; Yuchong Zhao; Yun Wang; Zhenxiong Zhao; Qian Chen; Yaqi Duan; Si Xiong; Zhou Luan; Jinlin Wang; Bin Cheng
Journal: Clin Transl Gastroenterol Date: 2022-05-01 Impact factor: 4.396

9 in total